[
  {
    "criterion": "Provides a clear and concise overview of the rationale for using gentamicin and ampicillin synergy in enterococcal endocarditis.",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Incorrectly states that gentamicin dosing should be adjusted based on serum potassium levels.",
    "axis": "accuracy",
    "point": -6
  },
  {
    "criterion": "Asks the user to clarify their request to ensure a more accurate response.",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Response uses natural language and correct interpretation, avoiding jargon and technical terms that might confuse the user.",
    "axis": "communication_quality",
    "point": 7
  },
  {
    "criterion": "Provides an incorrect reference for the information provided, citing an unreliable source.",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Correctly adjusts gentamicin dosing based on the patient's creatinine clearance (CrCl) or estimated GFR, as recommended by IDSA guidelines.",
    "axis": "completeness",
    "point": 10
  },
  {
    "criterion": "Fails to mention the importance of monitoring renal function during gentamicin therapy in patients with decreased eGFR.",
    "axis": "completeness",
    "point": -4
  },
  {
    "criterion": "Clearly states the recommended gentamicin synergy dose alongside ampicillin for enterococcal endocarditis, citing relevant clinical pharmacokinetics references.",
    "axis": "accuracy",
    "point": 9
  },
  {
    "criterion": "Mentions the potential for nephrotoxicity and ototoxicity with gentamicin therapy, but does not provide any guidance on monitoring for these effects.",
    "axis": "communication_quality",
    "point": 4
  }
]